K.
K. Maphosa@k_maphosa·Bearish
sygnia bleeding rand weakness tho. medical device play should have some export buffer but if their fx hedging is weak or they're sourcing offshore, margins get squeezed fast. where's the last sens on capex spend or new product pipeline. feels quiet.